Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Biopolymer-foams-for-use-in-tissue-repair-and-reconstruction

 Immunoliposomes that optimize internalization into target cells
The present invention provides novel immunoliposomes optimized for delivering therapeutic agents to ...


 Virus-like particles for the induction of autoantibodies
The inventors have discovered compositions and methods of increasing the titers of antibodies to ...


 Ferritin analogs
Despite the fact that ferritin is extremely selective in accumulating, storing and dispensing iron ...


 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
What is claimed is: 1. A method for the treatment of a tumor in a mammal, comprising the steps of (...


 Methods for diagnosing early Lyme disease
This invention is based upon the discovery that sera from patients with early Lyme disease contain ...


 Tango 243 polypeptides and uses thereof
The present invention is based, at least in part, on the discovery of cDNA molecules which encode ...


 Dermatophagoides proteins and fragments thereof
What is claimed is: 1. An isolated protein comprising an amino acid sequence selected from the ...


 Tuberculin active proteins and peptides from the cells of tubercle bacilli
What is claimed is: 1. A tuberculin active simple protein from Mycobacterium tuberculosis strain A...


 Therapy for injured muscles
We claim: 1. A method for treating an injured muscle, the method comprising the step of local ...


 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1. PRO1560 A cDNA clone (DNA19902-1669) has been identified that encodes a novel polypeptide ...


 Biopolymer foams for use in tissue repair and reconstruction

Details
Inventors: Bell, Eugene; Sioussat, Tracy M.; Fofonoff, Timothy W.;
Assignee: Tissue Engineering, Inc. (Boston, MA)
Primary Examiner: Bell; James J.
Assistant Examiner: Copenheaver; Blaine R
Attorney, Agent or Firm: Lahive & Cockfield, LLP, Smurzynski; Thomas V.

Single and double density biopolymer foams, composite biopolymer foams including both single and double density foams, and methods of preparing these foams and composite foams are described. Also described are biocompatible constructs which include single or double density biopolymer foams and extracellular matrix particulates and methods of preparing these constructs. The foams, composite foams, and biocompatible constructs of the invention can be used in tissue repair and reconstruction.

DETAILED DESCRIPTION OF THE INVENTION The present invention features biopolymer foams, composite biopolymer foams, biocompatible constructs comprising biopolymer foams and extracellular matrix particulates and methods for making and using these foams and foam compositions.
A biopolymer is a polymer which is suitable for introduction into a living organism, e.
g.
, a mammal, e.
g.
, a human.
Preferably, the biopolymer is non-toxic and bioabsorbable when introduced into a living organism and any degradation products of the biopolymer are also non-toxic to the organism.
The biopolymers of the invention can be formed into biocompatible foams, e.
g.
, single or double density foams, composite foams, and biocompatible constructs which include biopolymer fibers, e.
g.
, collagen fibers, biopolymer fabrics, e.
g.
, collagen fabrics, and/or extracellular matrix particulates.
Examples of biopolymers which can be used in the present invention include collagen, alginic acid, polyvinyl alcohol, proteins, such as chondroitin sulfate, elastin, laminin, heparan sulfate, fibronectin and fibrinogen.
In one embodiment, a combination or mixture of one or more biopolymers can be used to form the biopolymer forms, e.
g.
, fibers, foams, and foam compositions of the invention.
For example, a combination of chondroitin sulfate and fibronectin can be used to form the biopolymer fibers described herein.
A preferred biopolymer is collagen.
Preferred sources of biopolymers include mammals such as pigs, e.
g.
, near-term fetal pigs, sheep, and cows.
Other sources of the biopolymers include both land and marine vertebrates and invertebrates.
In one embodiment, the collagen can be obtained from skins of near-term, domestic porcine fetuses which are harvested intact, enclosed in their amniotic membranes.
Collagen or combinations of collagen types can be used in the foams and foam compositions described herein.
A preferred combination of collagen types includes collagen type I, collagen type III, and collagen type IV.
Preferred mammalian tissues from which to extract the biopolymer include entire mammalian fetuses, e



Related patents
  Periodate oxidative method for attachment of biomolecules to medical device surfaces
OF THE INVENTION As used in the specification and claims hereof, the following terms have the particular meanings and definitions set forth below. I define the term "...
  Self-aligning peptides modeled on human elastin and other fibrous proteins
OF PREFERRED EMBODIMENTS The present invention is directed to unique polypeptides modeled on human elastin and other naturally occurring fibrous proteins. While the ...
  Prosthetic devices including elastin or elastin-based materials
It is a specific object of the invention to provide an elastin-based prosthetic device suitable for use as a stent, for example, a vascular stent. The present invention ...
  Peptides containing N-substituted L-amino acids for preventing .beta.-strand association
The invention claimed is: 1. A peptide comprising a peptide, wherein: (a) said peptide comprises a .beta.-strand-forming section, said section consisting of four to ...
  Lectins and antiretroviral drugs containing the lectins as active ingredient
OF THE INVENTION The lectins of the present invention are obtained from the plants of the class Dicotyledoneae and have a function for inhibiting the reverse ...
  Activated dendritic cells and methods for their activation
The present invention pertains to a method of activating dendritic cells to enhance antigen presenting capacity. The activated, antigen-presenting dendritic cells of the ...
  Methods and compositions for obtaining mature dendritic cells
OF THE INVENTION This invention relates to methods and compositions useful for promoting the maturation of immature dendritic cells to a mature and stable phenotype as ...
  Nucleic acid encoding a lectin-derived progenitor cell preservation factor
It has now been discovered that these and other objectives can be achieved by the present invention, which provides an isolated nucleic acid comprising a nucleotide ...
  Ligand for vascular endothelial growth factor receptor
We claim: 1. A compound comprising amino acid sequence Glu-Ile-Glu-Trp-Tyr-Ser-Trp-Val-Thr-His-Gly-Met-Tyr (SEQ ID NO:29). 2. A pharmaceutical composition comprising ...
  Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
What is claimed is: 1. An immunologically active Borrelia burgdorferi protein free of other proteins isolated from Borrelia burgdorferi, which protein comprises SEQ ID NO...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved